Hospital News and Research

RSS

Quidel acquires Diagnostic Hybrids for $130 million

Quidel Corporation, a leading provider of rapid diagnostic tests, has completed its previously announced acquisition of Diagnostic Hybrids, Inc. for approximately $130 million in cash.

20 Feb 2010

Workforce issues: Health care jobs boom in Nevada; Florida nurses lobby for safer hospital staffing

News outlets report on the health care workforce, including the thriving job market in Nevada and an effort to institute mandatory staffing ratios for nurses in Florida hospitals.

20 Feb 2010

Health care fraud: Massachusetts hospital to pay $2.79M for settling False Claims Act allegations

Mercy Hospital Inc. (d/b/a Mercy Medical Center) of Springfield, Mass., has agreed to pay the United States $2,799,462 to settle claims that it violated the False Claims Act between 2005 and 2006 by failing to provide, or failing to document that it provided, the minimum number of hours of rehabilitation therapy required under Medicare guidelines, the Justice Department announced today.

20 Feb 2010

Stalled health bills could lead to increase in hospital mergers

Some analysts expect an increase in hospital mergers if health care overhaul remains stalled and the head of the Cleveland Clinic discusses why he thinks an overhaul won't lower health costs.

20 Feb 2010

Amgen's Prolia Complete Response submission: FDA classifies and sets PDUFA date

Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has evaluated the content of the Company's Complete Response submission for Prolia™ (denosumab) in the treatment of postmenopausal osteoporosis and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act (PDUFA) action date of July 25, 2010.

20 Feb 2010

Animal study shows calcineurin enzyme is critical for normal heart function

Scientists are reporting the first-ever data to show that the enzyme calcineurin is critical in controlling normal development and function of heart cells, and that loss of the protein leads to heart problems and death in genetically modified mice.

20 Feb 2010

Emory School of Medicine to enroll nearly 1,140 people for Phase III clinical trial of progesterone for TBI

Researchers at 17 medical centers across the country soon will begin using the hormone progesterone to treat patients who experience traumatic brain injury (TBI). The treatment is part of a randomized, double-blind Phase III clinical trial that will enroll approximately 1,140 people over a three- to six-year period beginning in March, 2010. The trial is funded by a grant to Emory University from the National Institutes of Health.

20 Feb 2010

New guidance document to prevent food allergies

For the first time, national authorities carrying out official food allergen controls have a common basis for accepting validated testing methods. Consumers allergic to certain food ingredients will benefit from an increased level of protection by the availability of harmonised and reliable testing methods, and international trade will be facilitated by applying mutually-agreed testing protocols.

19 Feb 2010

First Physicians Capital Group's first fiscal quarter Net Revenue from Services rises 32%

First Physicians Capital Group, Inc., an operator of healthcare services firms primarily in rural and suburban markets in the U.S., reported results for the Company’s first fiscal quarter ended December 31, 2009 and delivered today the following update to shareholders from FPCG’s CEO, David Hirschhorn.

19 Feb 2010

Polyphor discovers new class of antibiotics effective against multi-drug resistant Gram-negative bacteria

Today, Polyphor Ltd published the discovery of a new class of antibiotics with a novel mode of action (Science, VOL 327, ISSUE 5968). This proprietary new class of antibiotics is effective against multi-drug resistant Gram-negative bacteria, opening up new treatment options for serious and often life-threatening infections. The most advanced drug candidate in this new class, POL7080, selectively kills the dangerous bacteria Pseudomonas aeruginosa.

19 Feb 2010

Loxogon's new healthcare software application integrates multiple hospital information systems in real-time

Loxogon, Inc. today announced the release of a new healthcare software application specializing in operational intelligence solutions.

19 Feb 2010

LifePoint Hospitals reports fourth-quarter and full-year 2009 financial results

LifePoint Hospitals, Inc. today announced results for the fourth quarter and year ended December 31, 2009.

19 Feb 2010

CMAJ study summarizes risk factors for severe outcome among patients admitted to hospital with H1N1

A new study in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/cgi/doi/10.1503/cmaj.091823 of all patients in Canada admitted to hospital for H1N1 in the first five months of the outbreak summarizes the risk factors for a severe outcome (www.cmaj.ca). The H1N1 pandemic presents important learnings for clinicians and researchers and data on severe outcomes can help inform future treatment and prevention guidelines.

19 Feb 2010

Ontario government should fund $6M deficit of North Bay General Hospital: OCHU/CUPE

The Ontario government should fund the $6 million deficit of the North Bay General Hospital, Ontario Council of Hospital Unions/CUPE requested today. OCHU represents 25,000 nurses, tradespersons, clerical, housekeeping, dietary and support and service staff at 65 Ontario hospitals, including employees represented by CUPE Local 139 at the North Bay General Hospital.

19 Feb 2010

Accessing out of hours care: Challenging for UK palliative care patients

Accessing out of hours care is still a challenge for UK palliative care patients, even several years after the introduction of phone help line services like NHS24 and NHS Direct. Scottish researchers have specific recommendations for a more detailed and regular communication strategy to improve patients' care, which are published by SAGE in the journal Palliative Medicine.

19 Feb 2010

Embrella Embolic Deflector device highlighted during JIM 2010 meeting in Rome

Embrella Cardiovascular™, Inc., a privately held company announced that the Embrella Embolic Deflector™ device was highlighted during a live case transmission last week at the Joint Interventional Meeting (JIM) in Rome, Italy.

19 Feb 2010

SSHS selects Eclipsys’ Sunrise Enterprise suite of solutions for integrating EHR across multiple care venues

Eclipsys Corporation®, The Outcomes Company®, today announced that Sound Shore Health System (SSHS) will undergo an accelerated activation of Eclipsys’ Sunrise Enterprise™ integrated suite of solutions at both its Sound Shore Medical Center of Westchester (New Rochelle, NY) and Mount Vernon Hospital (Mount Vernon, NY) facilities.

19 Feb 2010

Delay in Vibativ's approval for nosocomial pneumonia to reduce previously forecasted commercial impact

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that delays in the U.S. approval and launch of Theravance/Astellas's Vibativ (telavancin) for the treatment of nosocomial pneumonia will reduce by more than half the commercial impact that it was previously forecasted to garner in the methicillin-resistant Staphylococcus aureus (MRSA) drug market.

19 Feb 2010

Emerging concepts from gene regulation studies in immune cells

The seventh meeting in the “Emergence and Convergence” series jointly organized by La Fondation IPSEN and Nature brings together today in San Antonio (Texas, USA) leading experts to discuss concepts emerging from gene regulation studies in immune cells that have led to insights into the initiation and maintenance of epigenetic chromatin marks necessary for proper differentiation and function of these cells in the immune system.

19 Feb 2010

Contrast-enhanced MRI may help physicians differentiate between rheumatoid and psoriatic arthritis

Contrast-enhanced magnetic resonance imaging (MRI) may help physicians differentiate between rheumatoid arthritis and psoriatic arthritis in the hand and wrist enabling more targeted therapies unique to each condition, according to a study in the March issue of the American Journal of Roentgenology. Contrast-enhanced MRI uses contrast media to improve the visibility of internal bodily structures.

19 Feb 2010

Hospital News and Research

Quidel acquires Diagnostic Hybrids for $130 million

Workforce issues: Health care jobs boom in Nevada; Florida nurses lobby for safer hospital staffing

Health care fraud: Massachusetts hospital to pay $2.79M for settling False Claims Act allegations

Stalled health bills could lead to increase in hospital mergers

Amgen's Prolia Complete Response submission: FDA classifies and sets PDUFA date

Animal study shows calcineurin enzyme is critical for normal heart function

Emory School of Medicine to enroll nearly 1,140 people for Phase III clinical trial of progesterone for TBI

New guidance document to prevent food allergies

First Physicians Capital Group's first fiscal quarter Net Revenue from Services rises 32%

Polyphor discovers new class of antibiotics effective against multi-drug resistant Gram-negative bacteria

Loxogon's new healthcare software application integrates multiple hospital information systems in real-time

LifePoint Hospitals reports fourth-quarter and full-year 2009 financial results

CMAJ study summarizes risk factors for severe outcome among patients admitted to hospital with H1N1

Ontario government should fund $6M deficit of North Bay General Hospital: OCHU/CUPE

Accessing out of hours care: Challenging for UK palliative care patients

Embrella Embolic Deflector device highlighted during JIM 2010 meeting in Rome

SSHS selects Eclipsys’ Sunrise Enterprise suite of solutions for integrating EHR across multiple care venues

Delay in Vibativ's approval for nosocomial pneumonia to reduce previously forecasted commercial impact

Emerging concepts from gene regulation studies in immune cells

Contrast-enhanced MRI may help physicians differentiate between rheumatoid and psoriatic arthritis

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News